About this trial
This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.
Eligibility criteria
Qualifiers
Over 30% of testing rates on at least one of the three index procedures (breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair)
Disqualifiers
none
Trial design
Treatments tested in this trial
- Active de-Implementation
Treatment groups
6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
University of Michigan
Lead sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
Blue Cross Blue Shield of Michigan Foundation
Collaborator